A Phase II Study of AT7519M, a CDK Inhibitor, in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia
Clinical trial NCT01627054 · COMPLETED
Trial details
- NCT number
- NCT01627054
- Sponsor
- NCIC Clinical Trials Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-27
- Primary completion
- 2014-03-21
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.